Perspective Therapeutics (CATX) Total Debt (2023 - 2026)

Perspective Therapeutics' Total Debt history runs 4 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• In Q1 2026, Total Debt fell 3.54% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 3.54% YoY), while the FY2025 annual figure was $1.6 million, down 3.45% from the prior year.
• Total Debt came in at $1.6 million for Q1 2026 at Perspective Therapeutics, down from $1.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $1.7 million in Q1 2023 to a low of $1.6 million in Q1 2026.
• A 4-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Total Debt.
• Across the five-year window, Total Debt slipped 2.92% in 2024 and fell 3.54% in 2026, its largest moves.
• Perspective Therapeutics' Total Debt stood at $1.7 million in 2023, then retreated by 3.04% to $1.6 million in 2024, then slipped by 3.45% to $1.6 million in 2025, then declined by 0.96% to $1.6 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $1.6 million, $1.6 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison